Glycogen phosphorylase BB could be a new biomarker for detection of cardiac toxicity during hematopoietic cell transplantation for hematological malignancies

Bone Marrow Transplantation

Volumn 45, Issue 6, 2010, Pages 1123-1124

  Horacek, J M ^a,b   Jebavy, L ^a,b   Ulrychova, M ^a   Tichy, M ^a   Pudil, R ^a   Zak, P ^a   Maly, J ^a  

^a UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; GLYCOGEN PHOSPHORYLASE B; GLYCOGEN PHOSPHORYLASE BB; MYOGLOBIN; TROPONIN I; UNCLASSIFIED DRUG; GLYCOGEN PHOSPHORYLASE; GLYCOGEN PHOSPHORYLASE BB, HUMAN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CARDIOTOXICITY; CHRONIC MYELOID LEUKEMIA; DIASTOLIC HEART FAILURE; HEART INJURY; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; LETTER; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; ADULT; COMPLICATION; FEMALE; HEART DISEASES; HEMATOLOGIC NEOPLASMS; MALE; MIDDLE AGED;

ADULT; BIOLOGICAL MARKERS; FEMALE; GLYCOGEN PHOSPHORYLASE; HEART DISEASES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED;

EID: 77954864414     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.306     Document Type: Letter

References (6)

1. Tichelli A, Bhatia S, Socie G. Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br J Haematol 2008; 142: 11-26.
2. Morandi P, Ruffini PA, Benvenuto GM, Raimondi R, Fosser V. Cardiac toxicity of high-dose chemotherapy. Bone Marrow Transplant 2005; 35: 323-334.
3. Gertz MA. Troponin in hematologic oncology. Leuk Lymphoma 2008; 49: 194-203.
4. Sparano JA, Brown DL, Wolff AC. Predicting cancer therapyinduced cardiotoxicity. The role of troponins and other markers. Drug Saf 2002; 25: 301-311.
5. Horacek JM, Tichy M, Pudil R, Jebavy L, Zak P, Ulrychova M et al. Multimarker approach to evaluation of cardiac toxicity during preparative regimen and hematopoietic cell transplantation. Neoplasma 2008; 55: 532-537.
6. Horacek JM, Tichy M, Pudil R, Jebavy L. Glycogen phosphorylase BB could be a new circulating biomarker for detection of anthracycline cardiotoxicity [letter]. Ann Oncol 2008; 19: 1656-1657.